BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 11390535)

  • 1. Detecting colorectal cancer in stool with the use of multiple genetic targets.
    Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
    J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
    Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
    Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF, K-ras and BAT26 mutations in colorectal polyps and stool.
    Jin YM; Li BJ; Qu B; Du YJ
    World J Gastroenterol; 2006 Aug; 12(32):5148-52. PubMed ID: 16937524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal multiple molecular tests to detect colorectal cancer in stool.
    Calistri D; Rengucci C; Bocchini R; Saragoni L; Zoli W; Amadori D
    Clin Gastroenterol Hepatol; 2003 Sep; 1(5):377-83. PubMed ID: 15017656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of the mutated K-Ras biomarker in colorectal carcinoma.
    Doolittle BR; Emanuel J; Tuttle C; Costa J
    Exp Mol Pathol; 2001 Jun; 70(3):289-301. PubMed ID: 11418008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stool DNA-based colorectal cancer detection: finding the needle in the haystack.
    Atkin W; Martin JP
    J Natl Cancer Inst; 2001 Jun; 93(11):798-9. PubMed ID: 11390522
    [No Abstract]   [Full Text] [Related]  

  • 8. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.
    Zou H; Taylor WR; Harrington JJ; Hussain FT; Cao X; Loprinzi CL; Levine TR; Rex DK; Ahnen D; Knigge KL; Lance P; Jiang X; Smith DI; Ahlquist DA
    Gastroenterology; 2009 Feb; 136(2):459-70. PubMed ID: 19026650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer.
    Lev Z; Kislitsin D; Rennert G; Lerner A
    J Cell Biochem Suppl; 2000; 34():35-9. PubMed ID: 10762013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple detection of genetic alterations in tumors and stool.
    Rengucci C; Maiolo P; Saragoni L; Zoli W; Amadori D; Calistri D
    Clin Cancer Res; 2001 Mar; 7(3):590-3. PubMed ID: 11297253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
    Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
    Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.
    Sidransky D; Tokino T; Hamilton SR; Kinzler KW; Levin B; Frost P; Vogelstein B
    Science; 1992 Apr; 256(5053):102-5. PubMed ID: 1566048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.
    Nishikawa T; Maemura K; Hirata I; Matsuse R; Morikawa H; Toshina K; Murano M; Hashimoto K; Nakagawa Y; Saitoh O; Uchida K; Katsu K
    Clin Chim Acta; 2002 Apr; 318(1-2):107-12. PubMed ID: 11880119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
    Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults.
    Haug U; Hillebrand T; Bendzko P; Löw M; Rothenbacher D; Stegmaier C; Brenner H
    Clin Chem; 2007 Apr; 53(4):787-90. PubMed ID: 17317884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection.
    Brand RE; Ross ME; Shuber AP
    Am J Gastroenterol; 2004 Jul; 99(7):1338-41. PubMed ID: 15233675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces.
    Ratto C; Flamini G; Sofo L; Nucera P; Ippoliti M; Curigliano G; Ferretti G; Sgambato A; Merico M; Doglietto GB; Cittadini A; Crucitti F
    Dis Colon Rectum; 1996 Nov; 39(11):1238-44. PubMed ID: 8918432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of K-ras point mutations in the stool of patients with colorectal tumors].
    Kohata Y
    Nihon Shokakibyo Gakkai Zasshi; 1996 Jun; 93(6):391-7. PubMed ID: 8752756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer.
    Eguchi S; Kohara N; Komuta K; Kanematsu T
    Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.